CLVLY Clinuvel Pharmaceuticals Ltd. Forecast, Technical & Fundamental Analysis

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria... Show more

Get AI intraday signals

Interact to see
Advertisement

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published Dividends

CLVLY paid dividends on September 30, 2024

Clinuvel Pharmaceuticals Ltd. CLVLY Stock Dividends

А dividend of $0.03 per share was paid with a record date of September 30, 2024, and an ex-dividend date of September 09, 2024. Read more...

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

535 Bourke Street

Phone

+61 396604900

Employees

Web

https://www.clinuvel.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
AAPL	200.42	0.21	+0.10%
Apple
SPY	587.73	-3.42	-0.58%
SPDR® S&P 500® ETF
BTC.X	107802.330000	-1192.312500	-1.09%
Bitcoin cryptocurrency
TSLA	356.90	-5.99	-1.65%
Tesla
GME	31.21	-3.80	-10.85%
GameStop Corp

CLVLY and Stocks

Correlation & Price change

A.I.dvisor tells us that CLVLY and BMNDF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLY and BMNDF's prices will move in lockstep.

Ticker / NAME	Correlation To CLVLY	1D Price Change %
CLVLY	100%	+5.23%
BMNDF - CLVLY	26% Poorly correlated	N/A
QLGN - CLVLY	21% Poorly correlated	+2.47%
ZLAB - CLVLY	21% Poorly correlated	-2.39%
MLEC - CLVLY	21% Poorly correlated	-5.45%
HLVX - CLVLY	21% Poorly correlated	-1.61%
More